Preoperative blood urea nitrogen-to-left ventricular ejection fraction ratio is an independent predictor of long-term major adverse cardiac events in patients undergoing coronary artery bypass grafting surgery

• Published in: Journal Of The Saudi Heart Association 2020-01, Vol.32 (1), p.79-85
• Main Authors: Erdogan, Turan, Çetin, Mustafa, Çinier, Goksel, Ozer, Savas, Yõlmaz, Ahmet S, Karakisi, Ozan, Kõrõs, Tuncay
• Format: Article
• Language: English
• Subjects: Original
• ISSN: 1016-7315; 2212-5043; 2212-5043
• DOI: 10.37616/2212-5043.1013

Long-term mortality rate following coronary artery bypass grafting (CABG) procedure is still considered to be high despite advances in surgical techniques and perioperative management. Identifying high-risk patients by using cost-effective and clinically useful parameters is needed. Patients who were admitted to our cardiology clinic with the diagnosis of coronary artery disease and underwent CABG between January 2008 and August 2010 were included. Study patients were followed-up for 112.6 ± 17.8 months for major adverse cardiac events (MACE) which were defined as all-cause mortality and new-onset decompensated heart failure (HF). Patients in MACE (+) group were older ( < 0.001), had higher additive Euroscore ( < 0.001), and lower left ventricular ejection fraction ( < 0.001). Multivariate Cox regression analysis showed that additive Euroscore [odds ratio (OR) = 1.601; 95% confidence interval (CI) = 1.374-1.864; < 0.001)] and blood urea nitrogen-to-left ventricular ejection fraction ratio (BUNEFr; OR = 1.028; 95% CI = 1.006-1.050; = 0.011) independently predicted MACE. Receiver operating characteristic curve analysis demonstrated that BUNEFr had an area under curve of 0.794 and BUNEFr >33 had a sensitivity and specificity of 74% and 64%, respectively. BUNEFr is a clinically useful and cost-effective parameter for the prediction of long-term mortality and new-onset decompensated HF in patients undergoing CABG.